Extracellular glycosidases of Bifidobacterium bifidum (None standardized for the whole group; individual enzymes have abbreviations (e.g., SiaBb2, AfcA).)

Extracellular glycosidases of *Bifidobacterium bifidum* refer collectively to a set of cell-surface or secreted enzymes capable of degrading complex host-derived carbohydrates, primarily human milk oligosaccharides (HMOs) and mucin O-glycans in the infant gut. Rather than a single molecule or receptor, this term encompasses several glycoside hydrolases—including sialidases (e.g., SiaBb2), fucosidases (AfcA, AfcB), lacto-N-biosidase, β-galactosidase, β-N-acetylhexosaminidase, and α-N-acetylglucosaminidase, among others. These enzymes are responsible for breaking down terminal modifications (fucose, sialic acid) and internal glycan structures, thereby enabling the bacterium to utilize otherwise indigestible host carbohydrates. Their activity facilitates bacterial colonization, nutrient acquisition, and symbiotic interactions with the host, contributing to the establishment and maintenance of a healthy gut microbiota, particularly in infants. This collection of enzymes is not considered a therapeutic target per se, nor a single molecular entity, but is relevant for understanding probiotic function, gut ecology, and host-microbe interaction.

Other names

Bifidobacterium bifidum extracellular glycosyl hydrolasesBifidobacterium bifidum cell surface glycosidasesBifidobacterium bifidum mucin O-glycan degrading enzymes

Enzymatic cleavage of host glycans (e.g., HMOs, mucins) to support Bifidobacterium growth and gut colonization. Release of mono- and disaccharides for metabolic use. Promotion of host adhesion through substrate modification and mucosal interactions.